Skip to main content
PRFX
NASDAQ Life Sciences

DeepSolar AI Platform Validated, Nearing Commercial Launch for Renewable Energy Optimization

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.31
Mkt Cap
$3.985M
52W Low
$1.23
52W High
$17.95
52W Position info
6.5% above low
Off High info
93% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

PRFX is trading near its 52-week low of $1.23 (6.5% above the low) on light trading volume (0.1× avg).

Summary

PRF Technologies announced the successful validation of its DeepSolar Predict™ AI platform using real-world data, moving it closer to commercial launch for renewable energy revenue optimization.


Key Events · Product Development and Regulatory · PRFX

  • DeepSolar Predict™ AI Platform Validation

    PRF Technologies' DeepSolar business unit successfully validated its Predict™ AI platform for renewable energy revenue optimization.

  • Advancing Towards Commercial Launch

    The validation marks another step toward the planned commercial launch of the AI-driven platform.

  • Real-World Data Application

    The validation applied real-world historical weather data, renewable energy production records, and market data from European energy markets.


Analysis · PRFX · Life Sciences

This filing reports a significant step forward for PRF Technologies' DeepSolar business unit, with the successful validation of its Predict™ AI platform. For a micro-cap company, progress in product development and movement towards commercialization is crucial for future revenue generation and investor confidence, especially following recent dilutive equity raises. This validation using real-world data enhances the platform's credibility and market readiness.

How filings like this one have moved

In the 30 days to Aug 22, 2026, 29.1% of the 2960 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.01%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PRFX was trading at $1.31 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4M. The 52-week trading range was $1.23 to $17.95. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PRFX - Latest Insights

PRFX
Jul 27, 2026, 8:47 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.11
Real-time Price: $0.9971 info
Change: -$0.1094 (-10%) info
Market Cap: $3.033M info
PRFX
Jul 08, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.43
Real-time Price: $0.9971 info
Change: -$0.4329 (-30%) info
Market Cap: $3.033M info
PRFX
Jun 29, 2026, 5:00 PM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $1.41
Real-time Price: $0.9971 info
Change: -$0.4129 (-29%) info
Market Cap: $3.033M info
PRFX
Jun 25, 2026, 4:15 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.58
Real-time Price: $0.9971 info
Change: -$0.5829 (-37%) info
Market Cap: $3.033M info
PRFX
Jun 25, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.49
Real-time Price: $0.9971 info
Change: -$0.4929 (-33%) info
Market Cap: $3.033M info